This was further supported by targeting CD33 in a mouse model of AD using an adeno-associated virus (AAV) vector encoding a CD33 microRNA (miRCD33), which demonstrated a reduction in amyloid β40 and β42 levels in brain extracts [24]. The gene discussed is CD33; the disease is Alzheimer disease.